Catalyst Wire Dossier Catalyst Wire Dossier

Adenovirus VEGF therapy

Ad-VEGF gene therapy (adenovirus-delivered VEGF) · Ark Therapeutics Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adenovirus VEGF therapy, covering 2010-11-19 to 2010-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Adenovirus Vascular Endothelial Growth Factor (VEGF) Therapy in Vascular Access - Novel Trinam AGainst Control Evidence [Phase 3]

See pricing